More than £15 billion was wiped from AstraZeneca’s market value on Monday after reports that the pharmaceutical group has held talks over a potential US$400 billion merger with US rival
Zevra Therapeutics (NASDAQ: ZVRA): “Multiple Approaches”
Sources familiar with the situation say the company has had multiple approaches around $20. They have recruited advisors to auction to the highest bidder from both the US and Europe.
Oxford Biodynamics Shares Soar over 115% on JAVELIN Bladder 100 Trial News
Pfizer publishes on successful use of EpiSwitch biomarkers evaluating tumour status and treatment outcomes from the JAVELIN Bladder 100 Trial
Mining companies drive gains in FTSE 100 following industrial expansion in China.
The FTSE 100 experienced a slight rise, driven by gains in metal mining stocks following positive economic indicators from China.
AstraZeneca enhances its earnings amid the emergence of legal proceedings related to vaccines.
AstraZeneca surpassed profitability expectations as it disclosed its third-quarter earnings, even as it confronts a significant legal challenge alleging that the effectiveness of its vaccines was greatly exaggerated.
AstraZeneca (LON:AZN) reaches a monthly peak due to positive outcomes from a breast cancer medication trial.
Shares of AstraZeneca PLC (LSE: AZN) have witnessed a 2% increase, surpassing 11,100p for the first time in a month, following the company’s announcement of promising results from an ongoing
AstraZeneca (LON:AZN) and Alexion collaborate with the FDA to broaden the US label for Ultomiris.
AstraZeneca PLC (LON: AZN) announced that the US Food and Drug Administration (FDA) has requested a risk assessment and mitigation strategy in response to a proposal to broaden the application
AstraZeneca subsidiary finalizes a US$1bn deal with Pfizer for rare diseases.
AstraZeneca has reported a stronger-than-anticipated performance in the second quarter, with robust sales from its leading cancer drugs offsetting the decline in Covid vaccine sales.
Share Talk Expected Market Updates For The Week Ahead, 8th – 12th May 2023
The upcoming week, spanning from May 8th to May 12th, begins with a Coronation bank holiday in the UK, followed by a focus on various businesses that have recently been
Share Talk Expected Market Updates For The Week Ahead, 1st – 5th May 2023
In the upcoming week, first-quarter updates from three of the FTSE 100’s five largest companies – HSBC, Shell, and BP – will be released, along with updates from a range
Share Talk Expected Market Updates For The Week Ahead, 31st October to the 4th November 2022
Over the week, earnings reports from the US include Airbnb, AMD and Coinbase, Illuminate, Moderna, Pfizer, Robinhood, Starbucks, Uber, and Virgin Galactic.
Oxford BioDynamics (AIM:OBD) US reimbursement code for EpiSwitch® CiRT
Issued US reimbursement code for Checkpoint Inhibitor Response Test (EpiSwitch® CiRT)